Multi-gene signatures in breast cancer: actual clinical impact

被引：0

作者：

Simon P. Gampenrieder

Gabriel Rinnerthaler

Richard Greil

机构：

[1] Paracelsus Medical University Salzburg,IIIrd Medical department with Hematology, Medical Oncology, Hemostaseology, Infectious Diseases and Rheumatology, Oncologic Center, Salzburg Cancer Research Institute with Laboratory of Immunological and Molecular Can

来源：

memo - Magazine of European Medical Oncology | 2014年 / 7卷 / 1期

关键词：

Breast cancer; Molecular pathology; Intrinsic subtypes; Gene expression; Prognostic; Predictive;

D O I：

10.1007/s12254-014-0130-3

中图分类号：

学科分类号：

摘要：

The molecular pathology has fundamentally modified our understanding of breast cancer. Today, breast cancer is understood as a heterogeneous disease consisting of at least five different subtypes. These subtypes show specific mRNA levels and somatic alterations and derive probably from different precursor cells. Multi-gene signatures enable us not only to differentiate these subtypes but also to define different risk groups for relapse after primary treatment. The clinical impact of these signatures is critically discussed in this review.

引用

页码：16 / 21

页数：5

共 50 条

[1] Multi-gene signatures in breast cancer: actual clinical impact
Gampenrieder, Simon P.
Rinnerthaler, Gabriel
Greil, Richard
[J]. MEMO-MAGAZINE OF EUROPEAN MEDICAL ONCOLOGY, 2014, 7 (01) : 16 - 21
[2] Impact of multi-gene mutational profiling on clinical trial outcomes in metastatic breast cancer
Rossanna C. Pezo
Tom W. Chen
Hal K. Berman
Anna M. Mulligan
Albiruni A. Razak
Lillian L. Siu
David W. Cescon
Eitan Amir
Christine Elser
David G. Warr
Srikala S. Sridhar
Celeste Yu
Lisa Wang
Tracy L. Stockley
Suzanne Kamel-Reid
Philippe L. Bedard
[J]. Breast Cancer Research and Treatment, 2018, 168 : 159 - 168
[3] Impact of multi-gene mutational profiling on clinical trial outcomes in metastatic breast cancer
Pezo, Rossanna C.
Chen, Tom W.
Berman, Hal K.
Mulligan, Anna M.
Razak, Albiruni A.
Siu, Lillian L.
Cescon, David W.
Amir, Eitan
Elser, Christine
Warr, David G.
Sridhar, Srikala S.
Yu, Celeste
Wang, Lisa
Stockley, Tracy L.
Kamel-Reid, Suzanne
Bedard, Philippe L.
[J]. BREAST CANCER RESEARCH AND TREATMENT, 2018, 168 (01) : 159 - 168
[4] Clinical utility of multi-gene testing in metastatic breast cancer
Bedard, P.
[J]. CANCER RESEARCH, 2017, 77
[5] Clinical impact of multi-gene panel testing for hereditary breast and ovarian cancer risk assessment
Ellisen, Leif W.
Kurian, Allison W.
Desmond, Andrea J.
Mills, Meredith
Lincoln, Stephen E.
Shannon, Kristen M.
Gabree, Michele
Tung, Nadine M.
Ford, James M.
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
[6] Multi-gene panels: new clinical experience in hereditary breast and ovarian cancer
Ramon y Cajal, T.
Lasa, A.
Llort, G.
Lopez, C.
Yague, C.
Cornet, M.
Gisbert, A.
Fisas, D.
Calvo, N.
Vethencourt, A.
Barba, A.
Quero, S.
Martinez, E.
Hernan, I.
Ruiz, A.
Arcusa, A.
Saigi, E.
Barnadas, A.
Surralles, J.
[J]. ANNALS OF ONCOLOGY, 2017, 28
[7] Multi-gene classifiers for prediction of recurrence in breast cancer
Naoi, Yasuto
Noguchi, Shinzaburo
[J]. ANNALS OF ONCOLOGY, 2015, 26 : 20 - 20
[8] Multi-gene classifiers for prediction of recurrence in breast cancer patients
Yasuto Naoi
Shinzaburo Noguchi
[J]. Breast Cancer, 2016, 23 : 12 - 18
[9] The performance of multi-gene panels for breast/ovarian cancer predisposition
Nunziato, Marcella
Scaglione, Giovanni Luca
Di Maggio, Federica
Nardelli, Carmela
Capoluongo, Ettore
Salvatore, Francesco
[J]. CLINICA CHIMICA ACTA, 2023, 539 : 151 - 161
[10] Multi-gene classifiers for prediction of recurrence in breast cancer patients
Naoi, Yasuto
Noguchi, Shinzaburo
[J]. BREAST CANCER, 2016, 23 (01) : 12 - 18

← 1 2 3 4 5 →